327 related articles for article (PubMed ID: 23951060)
1. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-132 cause apoptosis of glioma cells through blockade of the SREBP-1c metabolic pathway related to SIRT1.
Li Y; Zhang J; He J; Zhou W; Xiang G; Xu R
Biomed Pharmacother; 2016 Mar; 78():177-184. PubMed ID: 26898440
[TBL] [Abstract][Full Text] [Related]
3. MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway.
Zhang L; Huang D; Wang Q; Shen D; Wang Y; Chen B; Zhang J; Gai L
Cardiovasc Drugs Ther; 2014 Aug; 28(4):303-11. PubMed ID: 24924687
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Kanagasabai T; Li G; Shen TH; Gladoun N; Castillo-Martin M; Celada SI; Xie Y; Brown LK; Mark ZA; Ochieng J; Ballard BR; Cordon-Cardo C; Adunyah SE; Jin R; Matusik RJ; Chen Z
Cancer Lett; 2022 Jan; 525():46-54. PubMed ID: 34610416
[TBL] [Abstract][Full Text] [Related]
5. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.
Huang WC; Li X; Liu J; Lin J; Chung LW
Mol Cancer Res; 2012 Jan; 10(1):133-42. PubMed ID: 22064655
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
7. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
Guan M; Fousek K; Chow WA
FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C/EBPα/SREBP-1 pathway.
Pang B; Zhang J; Zhang X; Yuan J; Shi Y; Qiao L
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):354-364. PubMed ID: 33471067
[TBL] [Abstract][Full Text] [Related]
9. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.
Hsieh PF; Jiang WP; Basavaraj P; Huang SY; Ruangsai P; Wu JB; Huang GJ; Huang WC
Phytomedicine; 2021 Dec; 93():153806. PubMed ID: 34740154
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
11. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.
Li X; Chen YT; Hu P; Huang WC
Mol Cancer Ther; 2014 Apr; 13(4):855-66. PubMed ID: 24493696
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.
Zhang H; Feng Z; Huang R; Xia Z; Xiang G; Zhang J
Int J Oncol; 2014 Nov; 45(5):2143-52. PubMed ID: 25119660
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.
Wen YA; Xiong X; Zaytseva YY; Napier DL; Vallee E; Li AT; Wang C; Weiss HL; Evers BM; Gao T
Cell Death Dis; 2018 Feb; 9(3):265. PubMed ID: 29449559
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability.
Peng J; Yu J; Xu H; Kang C; Shaul PW; Guan Y; Zhang X; Su W
Cell Physiol Biochem; 2018; 47(2):784-799. PubMed ID: 29807364
[TBL] [Abstract][Full Text] [Related]
15.
Huang SY; Huang GJ; Wu HC; Kao MC; Huang WC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301150
[TBL] [Abstract][Full Text] [Related]
16. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.
Gu Y; Xue M; Wang Q; Hong X; Wang X; Zhou F; Sun J; Wang G; Peng Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948018
[No Abstract] [Full Text] [Related]
17. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα.
Zhong D; Zhang Y; Zeng YJ; Gao M; Wu GZ; Hu CJ; Huang G; He FT
Lipids Health Dis; 2013 Mar; 12():32. PubMed ID: 23496987
[TBL] [Abstract][Full Text] [Related]
19. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.
Yang M; Liu W; Pellicane C; Sahyoun C; Joseph BK; Gallo-Ebert C; Donigan M; Pandya D; Giordano C; Bata A; Nickels JT
J Lipid Res; 2014 Feb; 55(2):226-38. PubMed ID: 24296663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
